1,86% | % de acciones controlado por personas con información privilegiada |
69,11% | % de acciones controlado por instituciones |
70,42% | % de capital flotante controlado por instituciones |
625 | Número de participaciones de instituciones |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
ARK Investment Management, LLC | 8.157.028 | 30 mar 2024 | 9,61% | 439.745.378 |
Capital International Investors | 6.134.450 | 30 dic 2023 | 7,23% | 330.708.198 |
T. Rowe Price Investment Management, Inc. | 3.611.186 | 30 dic 2023 | 4,25% | 194.679.036 |
Nikko Asset Management Americas, Inc. | 3.369.762 | 30 dic 2023 | 3,97% | 181.663.868 |
Sumitomo Mitsui Trust Holdings, Inc. | 3.268.785 | 30 mar 2024 | 3,85% | 176.220.198 |
Blackrock Inc. | 2.516.486 | 30 dic 2023 | 2,96% | 135.663.759 |
FMR, LLC | 1.839.871 | 30 dic 2023 | 2,17% | 99.187.445 |
State Street Corporation | 1.753.497 | 30 dic 2023 | 2,07% | 94.531.023 |
Vanguard Group Inc | 1.590.651 | 30 dic 2023 | 1,87% | 85.751.995 |
NEA Management Company, LLC | 1.587.854 | 30 dic 2023 | 1,87% | 85.601.208 |
Accionista | Acciones | Fecha de notificación | % fuera | Valor |
---|---|---|---|---|
ARK ETF Tr-ARK Innovation ETF | 5.826.471 | 30 mar 2024 | 6,86% | 314.105.050 |
New Perspective Fund Inc | 4.698.706 | 30 mar 2024 | 5,54% | 253.307.239 |
ARK ETF Tr-ARK Genomic Revolution ETF | 1.701.130 | 30 mar 2024 | 2,00% | 91.707.918 |
SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF | 1.307.426 | 28 feb 2024 | 1,54% | 70.483.335 |
Price (T.Rowe) Mid Cap Growth Fund | 1.191.100 | 30 dic 2023 | 1,40% | 64.212.200 |
Vanguard Extended Market Index Fund | 1.180.449 | 30 dic 2023 | 1,39% | 63.638.005 |
Smallcap World Fund | 902.543 | 30 dic 2023 | 1,06% | 48.656.092 |
Growth Fund Of America Inc | 870.389 | 30 mar 2024 | 1,03% | 46.922.670 |
Fidelity Growth Company Fund | 587.344 | 30 ene 2024 | 0,69% | 31.663.714 |
iShares Biotechnology ETF | 581.887 | 28 feb 2024 | 0,69% | 31.369.528 |